Alaunos Therapeutics (TCRT) EBT Margin (2011 - 2025)
Alaunos Therapeutics (TCRT) recorded EBT Margin of -30233.33% in Q4 2025, down 11358.33 percentage points from -18875.00% a year earlier.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) EBT Margin (2011 - 2025) Analysis & Trends
For FY2025, Alaunos Therapeutics reported EBT Margin of -84500.00%, down 36380.00 percentage points from FY2024.
- Annual EBT Margin has a four-year change of -64812.75 percentage points (FY2021 to FY2025).
- Across earlier years, EBT Margin came in at -48120.00% in FY2024 (+675640.00 pp), -723760.00% in FY2023 (-722449.08 pp), -1310.92% in FY2022 (+18376.33 pp) and -19687.25% in FY2021.
- Quarterly EBT Margin has ranged from -794900.00% in Q4 2023 to -312.78% in Q3 2022 over the past five years.
- On a year-over-year basis, EBT Margin rose in three of the last four quarters, with an average year-over-year change of +270341.67 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Alaunos Therapeutics | 7.44 Mn | 3.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -30,233.33% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -18,875.00% |
| Jun 30, 2024 | -29,150.00% |
| Mar 31, 2024 | -174,200.00% |
| Dec 31, 2023 | -794,900.00% |
| Jun 30, 2023 | -226,250.00% |
| Dec 31, 2022 | -85,645.45% |
| Sep 30, 2022 | -312.78% |
| Dec 31, 2021 | -590,350.00% |
| Sep 30, 2021 | -5,713.57% |
| Mar 31, 2018 | -11,093.15% |
| Dec 31, 2017 | -841.33% |
| Sep 30, 2017 | -818.40% |
| Jun 30, 2017 | -814.90% |
| Mar 31, 2017 | -874.45% |
| Dec 31, 2016 | -695.74% |
| Sep 30, 2016 | -682.98% |
| Jun 30, 2016 | -7,733.77% |
| Mar 31, 2016 | -611.48% |
API Access
Alaunos Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();